Martin S. Tallman, MD @MartinTallman @sloan_kettering @WeillCornell #ASHPresident21 #ASH #Cancer #Research Begins Ter...

Cancer News Photo

Cancer News
2 years 22 Views

Martin S. Tallman, MD from Weill Cornell and Sloan Kettering discusses Martin S. Tallman, MD, Begins Term as 2021 ASH President.

Link to Article -,long%20term%20through%20December%202021.

Dr. Tallman is a medicine professor at Weill Cornell Medical College and the Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center in New York City, where he also holds the Cassidy Family Faculty Chair. Clinical studies in acute myeloid leukemia, acute lymphocytic leukemia, acute promyelocytic leukemia, and hairy cell leukemia are among Dr. Tallman's research interests.

Dr. Tallman has been a member of ASH for 21 years, during which time he has held numerous leadership positions for the Society, most recently as an ASH Councilor and Vice President. He served as the executive editor of Hematology, the Society's education program book, for three years, and he was a founding co-chair of the ASH Meeting on Hematologic Malignancies in 2015, and he continued to serve as co-chair in 2016. He's also taken part in a variety of ASH's educational and career development activities.

The American Society of Hematology (ASH) ( is the largest professional society of hematologists in the world, committed to improving the awareness, diagnosis, treatment, and prevention of blood disorders. The Society has been a driving force in the advancement of hematology as a discipline for more than 60 years, fostering science, patient care, education, training, and advocacy in the field. Blood (, the field's most cited peer-reviewed publication, and Blood Advances (, an online, peer-reviewed open-access journal, are both released by ASH.